Published in Hepatitis Weekly, March 4th, 1996
The report was one of several suggesting a response benefit to longer-term or higher-dose interferon in patients with chronic hepatitis delivered at the VII International Symposium on Viral Hepatitis, held January 25-27, 1996 in Madrid, Spain.
Researcher E. Minola and colleagues from Bergamo, Italy's Hospital Riuniti evaluated the efficacy of long-term interferon treatment in chronic hepatitis D virus (HDV) patients.
Chronic hepatitis D is usually a severe and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.